|Funding amount:||14.700.000 EUR|
|Funding Period:||2018 - 2023|
|Project leader:||Dr. Emilie Alirol|
Global Antibiotic Research & Development Partnership (GARDP)
15 Chemin Louis-Dunant
1202 Genf, Schweiz
A significant sexually transmitted infection (STI), Neisseria gonorrhoeae is threatening to soon become untreatable due to its resistance to all available classes of antimicrobials. This programme is designed to accelerate the entry of new antibiotics for the treatment of gonorrhea and to investigate the use of novel drug combinations.